Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
J. Clin. Invest. 102:6 doi:10.1172/JCI3714
[Go to this article.]

Problems with a PDF?

PDF - Download (284.87 KB)